Posts tagged validation program
3DS advances Hodgkin’s lymphoma test

The clinical trial component of 3D Signatures’ (OTCQB:TDSGF; TSXV:DXD; FSE:3D0) Hodgkin's lymphoma test (Telo-HL) validation program is under way. This process is referred to as Stage 3 of the validation program.

Read More
3DS initiates HL validation program

The validation program for 3D Signatures’ (TSX-V:DXD; OTCQB:TDSGF; FSE:3D0) Hodgkin's lymphoma test (Telo-HL) is under way. Telo-HL is powered by the company's TeloView software platform.

Read More